Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Banaszczak, M. (Marcin) | - |
dc.creator | Maciejewska, D. (Dominika) | - |
dc.creator | Drozd, A. (Arleta) | - |
dc.creator | Ryterska, K. (Karina) | - |
dc.creator | Jamiol-Milc, D. (Dominika) | - |
dc.creator | Raszeja-Wyszomirska, J. (Joanna) | - |
dc.creator | Wunsch, E. (Eva) | - |
dc.creator | Gonzalez-Muniesa, P. (Pedro) | - |
dc.creator | Stachowska, E. (Ewa) | - |
dc.date.accessioned | 2023-01-30T11:00:31Z | - |
dc.date.available | 2023-01-30T11:00:31Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Banaszczak, M. (Marcin); Maciejewska, D. (Dominika); Drozd, A. (Arleta); et al. "5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease". Medicina. 56(2):58. 2020, | es_ES |
dc.identifier.issn | 1648-9144 | - |
dc.identifier.uri | https://hdl.handle.net/10171/65194 | - |
dc.description.abstract | It was previously shown that a bodyweight reduction among patients with nonalcoholic fatty liver (NAFLD) was connected to the lower concentration of arachidonic and linoleic acid derivatives in their blood. We hypothesized that the concentration of these lipids was correlated with the extent of their body mass reduction and, thus, liver steatosis. Methods: We analyzed 68 individuals who completed the dietary intervention. Patients were divided into two groups depending on their body mass reduction (more or less than 7%). Before and after the dietary intervention, all patients had the following measurements recorded: body mass, waist circumference, stage of steatosis, fatty liver index, liver enzymes, lipid parameters, insulin and glucose. Concentrations of lipoxins A4 (LTX A4), hydroxyeicosatetraenoic fatty acids (5(S)-HETE, 12(S)-HETE and 16(S)-HETE), hydroxyoctadecaenoic acids (9(S)-HODE and 13(S)-HODE) and 5-oxo-eicosatetraenoic acid (5-oxo-ETE) were measured in serum samples collected before and after the dietetic intervention using high-performance liquid chromatography (HPLC). Results: Patients who reduced their body mass by more than 7% revealed a significant improvement in their steatosis stage, waist circumference, fatty liver index, triglycerides and cholesterol. Conclusion: A reduction in body mass by more than 7% but not by less than 7% revealed a significant improvement in steatosis stage; waist circumference; fatty liver index; and levels of triglycerides, cholesterol, 5-oxo-ETE and LTXA-4. | es_ES |
dc.description.sponsorship | The research project was supported by a grant from Narodowe Centrum Nauki (NCN), Nr N404 150539 and from the program of the Minister of Science and Higher Education under the name “Regional Initiative of Excellence” in 2019–2022, project number 002/RID/2018/19 amount of financing 12 000 000 PLN | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MDPI | es_ES |
dc.relation | 002/RID/2018/19 | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Derivatives | es_ES |
dc.subject | Nonalcoholic fatty liver | es_ES |
dc.subject | Oxylipids | es_ES |
dc.subject | Steatosis | es_ES |
dc.title | 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.description.note | This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license | es_ES |
dc.identifier.doi | 10.3390/medicina56020058 | - |
dadun.citation.number | 2 | es_ES |
dadun.citation.publicationName | Medicina | es_ES |
dadun.citation.startingPage | 58 | es_ES |
dadun.citation.volume | 56 | es_ES |
dc.identifier.pmid | 32028646 | - |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.